Kansas City Research Institute conducts clinical trials yielding results that empower medical professionals and patients to make informed health care decisions by advancing medical knowledge, promoting new and promising treatments, and facilitating access to otherwise unobtainable medications. Kansas City Research Institute led by liver specialist Dr. Bradley Freilich. Dr. Freilich has over 20 years of clinical research experience in phase 2-4 hepatology and gastroenterology trials, and has participated in close to a hundred research trials. KCRI opened a 20 bed phase one research center. While this facility will be able to do studies with healthy volunteers, our specialty is in trials for patients with liver disease, including looking at any drug that needs to be tested in hepatic impaired patient. KCRI also has experience in conducting Phase One Oncology Trials.